Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

BRCA1 is a histone-H2A-specific ubiquitin ligase.

Kalb R, Mallery DL, Larkin C, Huang JT, Hiom K.

Cell Rep. 2014 Aug 21;8(4):999-1005. doi: 10.1016/j.celrep.2014.07.025. Epub 2014 Aug 14.

PMID:
25131202
[PubMed - in process]
Free Article
2.

BRCA1/BARD1 E3 ubiquitin ligase can modify histones H2A and H2B in the nucleosome particle.

Thakar A, Parvin J, Zlatanova J.

J Biomol Struct Dyn. 2010 Feb;27(4):399-406.

PMID:
19916563
[PubMed - indexed for MEDLINE]
3.

Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.

Mallery DL, Vandenberg CJ, Hiom K.

EMBO J. 2002 Dec 16;21(24):6755-62.

PMID:
12485996
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.

Chen A, Kleiman FE, Manley JL, Ouchi T, Pan ZQ.

J Biol Chem. 2002 Jun 14;277(24):22085-92. Epub 2002 Apr 1.

PMID:
11927591
[PubMed - indexed for MEDLINE]
Free Article
5.

Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.

Xia Y, Pao GM, Chen HW, Verma IM, Hunter T.

J Biol Chem. 2003 Feb 14;278(7):5255-63. Epub 2002 Nov 12.

PMID:
12431996
[PubMed - indexed for MEDLINE]
Free Article
6.

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.

Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T.

J Biol Chem. 2001 May 4;276(18):14537-40. Epub 2001 Mar 6.

PMID:
11278247
[PubMed - indexed for MEDLINE]
Free Article
7.

Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

Dizin E, Irminger-Finger I.

Int J Biochem Cell Biol. 2010 May;42(5):693-700. doi: 10.1016/j.biocel.2009.12.025. Epub 2010 Jan 11.

PMID:
20060929
[PubMed - indexed for MEDLINE]
8.

Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.

Sato K, Hayami R, Wu W, Nishikawa T, Nishikawa H, Okuda Y, Ogata H, Fukuda M, Ohta T.

J Biol Chem. 2004 Jul 23;279(30):30919-22. Epub 2004 Jun 7.

PMID:
15184379
[PubMed - indexed for MEDLINE]
Free Article
9.

BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.

Nishikawa H, Wu W, Koike A, Kojima R, Gomi H, Fukuda M, Ohta T.

Cancer Res. 2009 Jan 1;69(1):111-9. doi: 10.1158/0008-5472.CAN-08-3355.

PMID:
19117993
[PubMed - indexed for MEDLINE]
Free Article
10.

BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.

Fabbro M, Rodriguez JA, Baer R, Henderson BR.

J Biol Chem. 2002 Jun 14;277(24):21315-24. Epub 2002 Mar 29.

PMID:
11925436
[PubMed - indexed for MEDLINE]
Free Article
11.

Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b.

Buchwald G, van der Stoop P, Weichenrieder O, Perrakis A, van Lohuizen M, Sixma TK.

EMBO J. 2006 Jun 7;25(11):2465-74. Epub 2006 May 18.

PMID:
16710298
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.

Morris JR, Solomon E.

Hum Mol Genet. 2004 Apr 15;13(8):807-17. Epub 2004 Feb 19.

PMID:
14976165
[PubMed - indexed for MEDLINE]
Free Article
13.

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.

Atipairin A, Canyuk B, Ratanaphan A.

Breast Cancer Res Treat. 2011 Feb;126(1):203-9. doi: 10.1007/s10549-010-1182-7. Epub 2010 Sep 29.

PMID:
20878461
[PubMed - indexed for MEDLINE]
14.

Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage.

Wang B, Elledge SJ.

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20759-63. Epub 2007 Dec 5.

PMID:
18077395
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair.

Sato K, Sundaramoorthy E, Rajendra E, Hattori H, Jeyasekharan AD, Ayoub N, Schiess R, Aebersold R, Nishikawa H, Sedukhina AS, Wada H, Ohta T, Venkitaraman AR.

Curr Biol. 2012 Sep 25;22(18):1659-66. doi: 10.1016/j.cub.2012.07.034. Epub 2012 Aug 2.

PMID:
22863316
[PubMed - indexed for MEDLINE]
Free Article
16.

Impact of RING and BRCT domain mutations on BRCA1 protein stability, localization and recruitment to DNA damage.

Nelson AC, Holt JT.

Radiat Res. 2010 Jul;174(1):1-13. doi: 10.1667/RR1290.1.

PMID:
20681793
[PubMed - indexed for MEDLINE]
17.

A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites.

Polanowska J, Martin JS, Garcia-Muse T, Petalcorin MI, Boulton SJ.

EMBO J. 2006 May 17;25(10):2178-88. Epub 2006 Apr 20.

PMID:
16628214
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Histone ubiquitination associates with BRCA1-dependent DNA damage response.

Wu J, Huen MS, Lu LY, Ye L, Dou Y, Ljungman M, Chen J, Yu X.

Mol Cell Biol. 2009 Feb;29(3):849-60. doi: 10.1128/MCB.01302-08. Epub 2008 Nov 17.

PMID:
19015238
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.

Sankaran S, Starita LM, Simons AM, Parvin JD.

Cancer Res. 2006 Apr 15;66(8):4100-7.

PMID:
16618730
[PubMed - indexed for MEDLINE]
Free Article
20.

Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.

Eakin CM, Maccoss MJ, Finney GL, Klevit RE.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5794-9. Epub 2007 Mar 28.

PMID:
17392432
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk